All studies
RecruitingTherapeutic exploratory (Phase II)Interventional

Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis - CiGal-EI-TEP

Infective endocarditis is a serious heart infection that can develop on replacement, or artificial, heart valves. Finding this infection quickly is vital, but standard scans do not always show it clearly. This trial is testing an advanced scan called a 68Ga-PET/CT. A PET/CT scan takes detailed 3D pictures of the inside of the body. In this study, doctors use a safe, mildly radioactive substance called Gallium 68 citrate, which acts as a highlighter for areas of inflammation and infection. Researchers want to see if this new scan is better at confirming heart valve infections than standard tests. They also want to find out if it can spot whether the infection has spread to other parts of the body. Taking part helps doctors learn if this scan should be used more widely to protect heart patients in the NHS and worldwide.

At a glance

Status
Recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
Centre Hospitalier Universitaire De Bordeaux
Enrolment target
40
Start
04 Jul 2024

What is this study about?

When someone receives an artificial heart valve, it helps their heart pump blood properly and improves their quality of life. However, bacteria or fungi can sometimes stick to the new valve, causing a severe infection known as infective endocarditis. Because an artificial valve is made of metal, plastic, or animal tissue, it is difficult for the body's immune system to fight off germs there. Diagnosing this infection early is crucial so that doctors can start the right antibiotics or plan surgery.

Currently, doctors use heart scans and blood tests to look for infection, but these tests can sometimes miss early warning signs or confuse normal healing with an infection. This clinical study is testing a promising scan known as a 68Ga-PET/CT. A PET/CT scan combines two types of imaging: a CT scan, which shows the structure of the heart, and a PET scan, which shows activity like inflammation.

To make the infection show up on the scan, a small amount of a tracking liquid called Gallium 68 citrate is injected into a vein. This liquid naturally travels to areas where the immune system is actively fighting germs, making infected spots 'light up' on the pictures. Researchers are comparing this scan to standard tests to see if it gives clearer, more reliable answers. If successful, this new method could help doctors diagnose heart valve infections faster and choose the best treatments for patients.

Key takeaways

  • Tests a new 68Ga-PET/CT scan to detect infections on artificial heart valves.
  • Uses a special tracer liquid that highlights areas of inflammation on the scan.
  • Open to adults aged 18 and over with an artificial valve and suspected infection.
  • The scan is painless, non-invasive, and uses a very low dose of radiation.
  • Aims to make heart valve infection diagnosis faster, clearer, and more accurate.

Who may be eligible?

This trial is designed for adults who have had heart surgery to replace a heart valve and are now suspected of having an infection on that valve. If your care team believes your artificial valve might be infected, you may be considered for this study.

Both men and women aged 18 and older can take part. Because the goal is to see how accurate the scan is when infection is suspected, participants must have an artificial heart valve and symptoms or test results that suggest a possible infection.

People who do not have an artificial heart valve, or those who are under 18 years of age, will not be able to join. The hospital team will check your overall health and medical history to make sure taking part is safe and suitable for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have had surgery in the past to replace a heart valve (artificial or tissue valve).
  3. My doctors suspect I might currently have an infection on my heart valve.
  4. I am able and willing to lie still in a hospital scanner for around 30 to 60 minutes.
Answer every question to see your result.

What does participation involve?

If you decide to take part, you will have an imaging appointment at the hospital. A doctor or nurse will place a small cannula (a soft plastic tube) into a vein in your arm. Through this, they will inject a small dose of the Gallium 68 tracer liquid. You will then wait a short while to allow the liquid to travel through your bloodstream to your heart.

Next, you will lie flat on a comfortable scanner bed that slowly moves through the PET/CT machine. The scan itself is painless and usually takes between 30 and 60 minutes. You will need to lie still while the pictures are taken. In some cases, doctors may compare these images with standard scans you might already need as part of your normal hospital care.

Your participation is focused on the scanning procedure and reviewing your medical records during your hospital stay. The researchers will track your diagnosis and recovery to see how well the scan predicted the infection. Your clinical team will explain the exact schedule and how long your visit will take before you agree to join.

Potential risks and benefits

A potential benefit is that the scan might provide extra, detailed information about your heart valve that could help your doctors manage your care, although this cannot be guaranteed. The main risk involves a small amount of radiation from the scan and tracer, similar to other standard hospital scans like CTs. The injection might cause minor bruising or tenderness around the needle site. Taking part is completely voluntary; you can choose to withdraw at any time without giving a reason, and your regular NHS medical care will not be affected in any way.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    France

Common questions

Will the scan hurt?

No, the scan itself is completely painless. You may only feel a brief scratch when the small tube is placed in your arm for the injection.

Is the radioactive tracer dangerous?

The Gallium 68 tracer uses a very low, carefully controlled amount of radiation. It leaves your body quickly through your urine and is considered safe for medical testing.

Will I have to stop taking my normal medicines?

Usually, you will continue your regular treatments, including any antibiotics. Your hospital doctor will give you clear instructions if you need to adjust any medicines before the scan.

Does this trial replace my usual heart treatment?

No. This study adds a specialised scan to help with diagnosis. Your doctors will continue to treat your heart condition according to standard NHS guidelines.

What happens if I change my mind about taking part?

You are free to leave the study at any point. Deciding not to take part will never change the quality of care or attention you receive from your medical team.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT)…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.